Cargando…
SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients
BACKGROUND: Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination reduces the risk and severity of coronavirus disease 2019 (COVID-19), several variables may impact the humoral response among patients undergoing hematopoietic stem cell transplantation (HSCT). METHODS: A r...
Autores principales: | Kokogho, Afoke, Crowell, Trevor A, Aleissa, Muneerah, Lupan, Ana-Mihaela, Davey, Sonya, Park Chang, Jun Bai, Baden, Lindsey R, Walsh, Stephen R, Sherman, Amy C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372870/ https://www.ncbi.nlm.nih.gov/pubmed/37520415 http://dx.doi.org/10.1093/ofid/ofad349 |
Ejemplares similares
-
1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT)
por: Kokogho, Afoke, et al.
Publicado: (2022) -
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant
por: Desjardins, Michaël, et al.
Publicado: (2021) -
Infection in the Hematopoietic Stem Cell Transplant Recipient
por: Marty, Francisco M., et al.
Publicado: (2008) -
2334. The effectiveness of bivalent COVID-19 booster among patients with hematologic malignancies
por: Aleissa, Muneerah M, et al.
Publicado: (2023) -
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients
por: Aleissa, Muneerah M., et al.
Publicado: (2023)